Researchers from the Massachusetts General Hospital (MGH) Cardiovascular Research Center have discovered what appears to be a master cardiac stem cell, capable of differentiating into the three major types of cells that make up the mammalian heart. In their report appearing in the Dec. 15 issue of the journal Cell and receiving early online release, the scientists describe identifying these progenitor cells in mice, cloning single cells from embryonic stem cells, and showing that these cloned cells can differentiate into cardiac muscle, smooth muscle or endothelial cells.
"These cells offer new prospects for drug discovery and genetically based models of human disease. They also give us a new paradigm for cardiac development, in which a single multipotent cell can diversify into both muscle and endothelial lineages," says Kenneth R. Chien, MD, director of the MGH Cardiovascular Research Center (CVRC) and senior author of the Cell paper. "They additionally suggest a novel strategy for the regeneration of cardiac muscle, coronary arterial and pacemaker cells." Chien also leads the cardiovascular program at the Harvard Stem Cell Institute, one of the study's supporters.
Several populations of embryonic cells that develop into the heart and associated structures have previously been indentified. It has been thought that the three types of cells that make up the heart itself – the contracting cardiac muscle cells and the smooth muscle and endothelial cells that make up blood vessels – all develop from different cellular progenitors. Two major groups of cardiac muscle progenitors, called the first and second field, have been identified.
In 2005, Chien's team, then at the University of California at San Diego, described finding a group of cardiac muscle progenitors called isl1+ cells in heart tissue from newborn rats, mice and humans. The islet-1 protein, for which isl1+ progenitors are named, is known to be expressed in cells from the second cardiac field, which generate the structures on the right side of the heart. The current study was designed to investigate whether islet-1 expressing cells give rise to more than just cardiac muscle cells.
In a variety of experiments, the researchers first identified a small population of embryonic islet-1-expressing cells that can develop into working cardiac muscle, smooth muscle, pacemaker cells and the endothelial cells lining the major vessels of the heart and the coronary arteries. Starting with embryonic stem cells from mice, they were able to generate these multipotent embryonic isl1+ progenitor cells (MIPCs) – the parental cells that give rise to the postnatal progenitor cells identified in the 2005 study – and to clone and expand their population in vitro.
The team's in vivo study of mouse embryos found within primitive cardiac tissues a small group of cells expressing islet-1 and two other important proteins called Nkx2.5 and flk1. The researchers cultured and cloned those cells and found they could differentiate into all three cardiac cells types, verifying that they were MIPCs. Expression of the Nkx2.5 and flk1 genes seems to play a role in the process by which the cells 'decide' their developmental fate.
"We think these are authentic cardiac stem cells that are responsible for forming the diverse cell types of the heart, although other cells also contribute to some structures," says Chien. "These MIPCs may be excellent candidates for cardiac muscle regeneration studies, without the risk of tumor formation posed by embryonic stem cells or the limited effectiveness seen in studies using other cell types.
"It now appears that cardiac cells develop in the same way that blood cells do, with a master stem cell giving rise to the entire range of cells. The search is now on for the hormones that trigger expansion of MIPCs, which would be analogous to the factors that drive blood formation." Chien was recently named the Sanders Professor of Basic Science at Harvard Medical School.
The same issue of Cell contains an accompanying article from the Children's Hospital Boston laboratory of Stuart Orkin, MD, and the Harvard Stem Cell Institute describing the discovery in the first cardiac field of progenitor cells expressing the Nkx2.5 protein that can generate both cardiac and smooth muscle cells. Sean Wu, MD, PhD, the first author of that paper, has recently joined the MGH-CVRC where he and Chien's team will follow up these seminal findings, including clarifying any developmental relationship between the two types of progenitor cells.
Sue McGreevey | EurekAlert!
International team discovers novel Alzheimer's disease risk gene among Icelanders
24.10.2016 | Baylor College of Medicine
New bacteria groups, and stunning diversity, discovered underground
24.10.2016 | DOE/Lawrence Berkeley National Laboratory
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Power and Electrical Engineering
24.10.2016 | Life Sciences
24.10.2016 | Life Sciences